MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,151 | -41.2% | 2,247 | -6.9% | 0.00% | 0.0% |
| Q2 2023 | $557,634 | +19.8% | 2,414 | +25.7% | 0.00% | 0.0% |
| Q1 2023 | $465,381 | +220.7% | 1,921 | +284.2% | 0.00% | – |
| Q4 2022 | $145,125 | +531.0% | 500 | +39.7% | 0.00% | – |
| Q3 2022 | $23,000 | +109.1% | 358 | +129.5% | 0.00% | – |
| Q2 2022 | $11,000 | -67.6% | 156 | -55.4% | 0.00% | – |
| Q1 2022 | $34,000 | +25.9% | 350 | +11.8% | 0.00% | – |
| Q4 2021 | $27,000 | +1250.0% | 313 | +1103.8% | 0.00% | – |
| Q3 2021 | $2,000 | -80.0% | 26 | -75.2% | 0.00% | – |
| Q2 2021 | $10,000 | -23.1% | 105 | -7.1% | 0.00% | – |
| Q1 2021 | $13,000 | +225.0% | 113 | +232.4% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 34 | +325.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 8 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | -93.8% | 8 | -96.6% | 0.00% | – |
| Q1 2020 | $16,000 | -23.8% | 236 | +3.5% | 0.00% | – |
| Q4 2019 | $21,000 | -4.5% | 228 | -12.0% | 0.00% | – |
| Q3 2019 | $22,000 | +633.3% | 259 | +735.5% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 31 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 31 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -85.7% | 31 | -68.4% | 0.00% | – |
| Q3 2018 | $21,000 | +50.0% | 98 | +92.2% | 0.00% | – |
| Q2 2018 | $14,000 | – | 51 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |